Trial Profile

American-Australian-African Trial With DronedarONe In Atrial Fibrillation or Flutter Patients for the Maintenance of Sinus Rhythm (ADONIS)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 12 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Jul 2022 Results of sub-analysis of the ATHENA and EURIDIS/ADONIS studies published in the Journal of Diabetes and its Complications
15 Jan 2022 Results (n=1795) of post hoc analysis of pooled data from two (EURIDIS and ADONIS) assessing the patient characteristics as predictors of dronedarone trough concentrations and characterized the relationship of the trough concentrations of dronedarone with its efficacy and safety, published in the Clinical Cardiology.
12 Jan 2022 Results (n=1229) of post hoc, pooled analysis from NCT00259428 and NCT00259376 assessing safety and efficacy of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function, published in the Clinical Cardiology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com